About Horizon Therapeutics
Horizon Therapeutics is a company based in Dublin (Ireland) founded in 2008 was acquired by Amgen in December 2022.. Horizon Therapeutics has raised $61.78 million across 7 funding rounds from investors including Amgen. Horizon Therapeutics has completed 5 acquisitions, including Crealta Pharmaceuticals, Nitec Pharma and Raptor Pharma. Horizon Therapeutics offers products and services including Biologic Medicines, DNA Encoded Libraries, and ATOMIC Model. Horizon Therapeutics operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Forge Biologics, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Amgen Inc.
-
Annual Revenue
$617.41 M14as on Dec 31, 2022
-
Net Profit
-
EBITDA
-
Total Equity Funding
$61.78 M (USD)
in 7 rounds
-
Latest Funding Round
$69.4 M (USD), Post-IPO
Oct 01, 2014
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Crealta Pharmaceuticals
& 4 more
-
Acquired by
Amgen
(Dec 12, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Horizon Therapeutics
Horizon Therapeutics offers a comprehensive portfolio of products and services, including Biologic Medicines, DNA Encoded Libraries, and ATOMIC Model. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for serious diseases using biologic agents
Platform for screening compounds in drug design
Machine learning for accelerating clinical trials
Unlock access to complete
Unlock access to complete
Software Development Team
208 people
Leadership Team
193 people
Sales and Marketing
82 people
Data Analysis and Operations Team
73 people
Senior Team
66 people
Operations Team
64 people
Product Management Team
55 people
Scientific Team
34 people
Unlock access to complete
Funding Insights of Horizon Therapeutics
Horizon Therapeutics has successfully raised a total of $61.78M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $69.4 million completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $69.4M
-
First Round
First Round
(28 Oct 2008)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2014 | Amount | Post-IPO - Horizon Therapeutics | Valuation |
investors |
|
| Nov, 2013 | Amount | Post-IPO - Horizon Therapeutics | Valuation |
investors |
|
| Mar, 2012 | Amount | Post-IPO - Horizon Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Horizon Therapeutics
Horizon Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Amgen. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of pharmaceutical products for treating multiple diseases
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Horizon Therapeutics
Horizon Therapeutics has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Crealta Pharmaceuticals, Nitec Pharma and Raptor Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of biologics for treating severe inflammation and autoimmune diseases
|
2017 | ||||
|
Biologic medicines are developed and manufactured for serious illnesses.
|
2013 | ||||
|
Developer of protein based therapeutics for the treatment of chronic granulomatous disease and malignant osteopetrosis
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Horizon Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Horizon Therapeutics Comparisons
Competitors of Horizon Therapeutics
Horizon Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Forge Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Horizon Therapeutics
Frequently Asked Questions about Horizon Therapeutics
When was Horizon Therapeutics founded?
Horizon Therapeutics was founded in 2008.
Where is Horizon Therapeutics located?
Horizon Therapeutics is headquartered in Dublin, Ireland.
Who is the current CEO of Horizon Therapeutics?
Timothy Walbert is the current CEO of Horizon Therapeutics.
Is Horizon Therapeutics a funded company?
Horizon Therapeutics is a funded company, having raised a total of $61.78M across 7 funding rounds to date. The company's 1st funding round was a Post-IPO of $65.93M, raised on Oct 28, 2008.
What is the annual revenue of Horizon Therapeutics?
Annual revenue of Horizon Therapeutics is $617.41M as on Dec 31, 2022.
What does Horizon Therapeutics do?
Developer of drugs for treating rare and autoimmune diseases. The lead candidates of the company are UPLIZNA fucosylated IgG 1 kappa (IgG1κ) monoclonal antibodies for myasthenia gravis, HZN-825 for idiopathic pulmonary fibrosis, and HZN-4920 for focal segmental glomerulosclerosis as well as kidney transplant rejection, rheumatoid arthritis, and Sjogrens syndrome.
Who are the top competitors of Horizon Therapeutics?
Horizon Therapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Horizon Therapeutics offer?
Horizon Therapeutics offers Biologic Medicines, DNA Encoded Libraries, and ATOMIC Model.
How many acquisitions has Horizon Therapeutics made?
Horizon Therapeutics has made 5 acquisitions, including Crealta Pharmaceuticals, Nitec Pharma, and Raptor Pharma.
Who are Horizon Therapeutics's investors?
Horizon Therapeutics has 1 investor. Key investors include Amgen.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.